Kin-Selected Senescence: Adaptive Aging via Mitochondrial ROS-Mediated Signaling

Hypothesis

Aging is maintained not as a passive byproduct but as an active, kin‑selected mechanism that limits individual lifespan to benefit relatives through controlled mitochondrial ROS release.

Mechanistic Basis

We propose that a conserved stress‑response pathway links the transcription factor FOXO3 to the mitochondrial inner‑membrane protein MICU1. When FOXO3 is activated by low‑level oxidative stress, it upregulates MICU1, which modulates calcium uptake and triggers a modest, sustained increase in matrix ROS. This ROS pulse acts as a diffusible signal that:

• induces senescence‑associated secretory phenotype (SASP) in nearby cells,
• elevates systemic inflammation that preferentially affects non‑relatives,
• reduces somatic growth and fecundity in the signal‑emitting individual,
• while providing a hormetic boost to germline stem cells in close kin via paracrine antioxidant uptake.

Thus the allele that strengthens this FOXO3‑MICU1 axis spreads because it raises inclusive fitness, even though it shortens the carrier’s life.

Testable Predictions

1. Individuals with higher basal FOXO3 activity will show elevated tissue‑specific MICU1 expression and a measurable increase in mitochondrial ROS that correlates with shorter lifespan.
2. Knocking down MICU1 in a model organism (e.g., C. elegans or mouse) will blunt the ROS signal, extend lifespan, and diminish the fitness benefit to nearby relatives measured by offspring survival.
3. Introducing a hyperactive FOXO3‑MICU1 construct will shorten lifespan but increase the reproductive success of siblings or cousins sharing the same environment, detectable as a rise in relative’s offspring number.
4. The ROS signal will be detectable in circulating extracellular vesicles and will carry a distinct oxidative lipid signature that can be transferred to kin‑derived cells in vitro, enhancing their stress resistance.

Potential Experiments

• Generate a CRISPR‑edited allele that increases FOXO3 binding to the MICU1 promoter in Drosophila; measure lifespan, mitochondrial ROS (using MitoSOX), and compare fecundity of edited flies versus wild‑type siblings kept in shared vials.
• In mice, create a conditional MICU1 knockout in liver; assess lifespan, serum inflammatory markers, and pup survival in litters housed with heterozygous littermates.
• Collect plasma from long‑lived humans with FOXO3 polymorphisms; isolate extracellular vesicles, quantify ROS‑laden lipids, and test their effect on cultured fibroblasts from younger relatives.

Falsifiability

If manipulations that reduce MICU1‑dependent ROS fail to extend lifespan or do not alter the fitness of nearby kin, the hypothesis that aging is an adaptively maintained kin‑selected trait is falsified. Likewise, if no correlation exists between FOXO3‑driven MICU1 expression and ROS levels across genotypes, the proposed mechanistic link is unsupported.